Forest (FRX) Commences Tender for Clinical Data (CLDA)
Down)
Forest Laboratories, Inc. (NYSE: FRX) has commenced a tender offer for Clinical Data, Inc. (Nasdaq: CLDA).
The tender offer is for $30.00 per share in cash plus contingent consideration of up to $6.00 per share that may be paid pursuant to the terms of a Contingent Value Agreement to be entered into by Forest, FL Holding CV, an indirect wholly-owned subsidiary of Forest, and Magnolia for the benefit of tendering security holders based upon achievement of certain milestones related to Viibryd.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
The tender offer is for $30.00 per share in cash plus contingent consideration of up to $6.00 per share that may be paid pursuant to the terms of a Contingent Value Agreement to be entered into by Forest, FL Holding CV, an indirect wholly-owned subsidiary of Forest, and Magnolia for the benefit of tendering security holders based upon achievement of certain milestones related to Viibryd.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Bazaarvoice (BV) Agrees to Buy PowerReviews; Offers Prelim. Q1 Results, Guides Q2, FY13
- KKR (KKR) Said to Be in Talks with Delek Group for Phoenix Holdings Stake
- China Investment may nab $2B stake in Alibaba - Reuters
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsRelated Entities
Forest Laboratories/Clinical DataSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
